Related references
Note: Only part of the references are listed.Construction and validation of a prognostic nomogram for anal squamous cell carcinoma
Ningning Yang et al.
CANCER MEDICINE (2022)
Establishment of predictive nomogram and web-based survival risk calculator for malignant pleural mesothelioma: A SEER database analysis
Sihao Chen et al.
FRONTIERS IN ONCOLOGY (2022)
Immunotherapy in malignant pleural mesothelioma: a long story ended in success
Alberto Bongiovanni et al.
JOURNAL OF CANCER METASTASIS AND TREATMENT (2022)
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
Paul Baas et al.
LANCET (2021)
Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma
Paolo Ghirardelli et al.
LUNG CANCER (2021)
Development and validation of a novel nomogram to predict cancer-specific survival in patients with uterine cervical adenocarcinoma
Xiao Ni et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Immune checkpoint inhibitors a new player in the therapeutic game of mesothelioma: New reality with new challenges
Kaushal Parikh et al.
CANCER TREATMENT REVIEWS (2021)
Development and validation of prognostic nomogram in ependymoma: A retrospective analysis of the SEER database
Zetian Jia et al.
CANCER MEDICINE (2021)
Addition of radiotherapy to surgery and chemotherapy improves survival in localized malignant pleural mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) study
Andrew B. Thompson et al.
LUNG CANCER (2020)
Development and validation of a nomogram for predicting late-onset sepsis in preterm infants on the basis of thyroid function and other risk factors: Mixed retrospective and prospective cohort study
Yuejun Huang et al.
JOURNAL OF ADVANCED RESEARCH (2020)
Clinical significance of histologic subtyping of malignant pleural mesothelioma
Luka Brcic et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
Michele Carbone et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Pain management in patients with malignant mesothelioma: challenges and solutions
J. Saunders et al.
LUNG CANCER-TARGETS AND THERAPY (2019)
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer
Zhongxing Liao et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review
Lisa Brusselmans et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
Characterizing CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy
A. Makkouk et al.
ANNALS OF ONCOLOGY (2017)
Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas
Felipe Nor et al.
CLINICAL CANCER RESEARCH (2017)
Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma
Fauzia Shaikh et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Radiotherapy for the treatment of malignant pleural mesothelioma
Marc de Perrot et al.
LANCET ONCOLOGY (2017)
Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases
Ahmad S. Alfaar et al.
CANCER MEDICINE (2017)
A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy
J. Li et al.
BRITISH JOURNAL OF CANCER (2014)
Current Issues in Malignant Pleural Mesothelioma Evaluation and Management
Jing Ai et al.
ONCOLOGIST (2014)
Malignant mesothelioma 2008
Michael D. Zervos et al.
CURRENT OPINION IN PULMONARY MEDICINE (2008)
Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma
GL Ceresoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)